230 related articles for article (PubMed ID: 31025490)
1. Different medications for the treatment of Ménière's disease by intratympanic injection: A systematic review and network meta-analysis.
Cao Z; Yue F; Huang W; Rajenderkumar D; Zhao F
Clin Otolaryngol; 2019 Jul; 44(4):619-627. PubMed ID: 31025490
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic gentamicin for Ménière's disease.
Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin for Ménière's disease or syndrome.
Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM
Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364
[TBL] [Abstract][Full Text] [Related]
8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic Treatment in Menière's Disease, Efficacy of Aminoglycosides Versus Corticosteroids in Comparison Studies: A Systematic Review.
Yaz F; Ziylan F; Smeeing DPJ; Thomeer HGXM
Otol Neurotol; 2020 Jan; 41(1):1-10. PubMed ID: 31789967
[TBL] [Abstract][Full Text] [Related]
10. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
Gabra N; Saliba I
Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Interventions for Menière's Disease: A Systematic Review and Network Meta-Analysis.
Zheng X; Lin R
Ear Nose Throat J; 2024 Jun; ():1455613241264421. PubMed ID: 38907653
[No Abstract] [Full Text] [Related]
12. Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease: a network meta-analysis.
Hao W; Yu H; Li H
J Neurol; 2022 Jan; 269(1):72-86. PubMed ID: 33387016
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies.
Phillips J; Mikulec AA; Robinson JM; Skarinsky D; Anderson JJ
Otol Neurotol; 2023 Jul; 44(6):584-592. PubMed ID: 37185596
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic therapy in Meniere's syndrome or disease: up to date evidence for clinical practice.
Syed MI; Ilan O; Nassar J; Rutka JA
Clin Otolaryngol; 2015 Dec; 40(6):682-90. PubMed ID: 25916787
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic steroids for Ménière's disease or syndrome.
Phillips JS; Westerberg B
Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
[TBL] [Abstract][Full Text] [Related]
16. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.
She W; Lv L; Du X; Li H; Dai Y; Lu L; Ma X; Chen F
J Laryngol Otol; 2015 Mar; 129(3):232-7. PubMed ID: 25655232
[TBL] [Abstract][Full Text] [Related]
18. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
19. Is low-dose intratympanic gentamicin an effective treatment for Ménière's disease: the Birmingham experience.
Watson GJ; Nelson C; Irving RM
J Laryngol Otol; 2015 Oct; 129(10):970-3. PubMed ID: 26328875
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
